CrossrefInfokarte
Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis
Journal of Hematology · 2024-04 · 13 (1-2) · 46-51
DOI: 10.14740/jh1242 ↗Abstract
Kein Abstract verfügbar.
EUVIMED